UPS: GERMAN BOLT-ON DEALAAPL: PAY YOUR DUESWTC: LOST FOR WORDS DSV: STEADY DOES ITRXO: COYOTE EQUITY FUNDING 'UPSIZED'RXO: RIGHTS ISSUEGXO: DEFENSIVEMAERSK: MSC RIVALRY INTENSIFIESWTC: REMARKABLY STRONG BA: LABOUR DEALFDX: NEW PARTNERATSG: RIVAL IPODSV: 'AHEAD IN BIDDING FOR SCHENKER'DSV: UNLUCKY FRIDAYSMAERSK: WEAK AGAIN
UPS: GERMAN BOLT-ON DEALAAPL: PAY YOUR DUESWTC: LOST FOR WORDS DSV: STEADY DOES ITRXO: COYOTE EQUITY FUNDING 'UPSIZED'RXO: RIGHTS ISSUEGXO: DEFENSIVEMAERSK: MSC RIVALRY INTENSIFIESWTC: REMARKABLY STRONG BA: LABOUR DEALFDX: NEW PARTNERATSG: RIVAL IPODSV: 'AHEAD IN BIDDING FOR SCHENKER'DSV: UNLUCKY FRIDAYSMAERSK: WEAK AGAIN
Dubai, UAE, Friday, 23rd September 2016 – The cool chain community must work closely with regulators to ensure the global pharma market, estimated to be worth USD1.1 trillion a year globally, benefits from harmonised regulations, delegates at the Cool Chain Association (CCA)’s Pharma and Biosciences Conference 2016 heard in Dubai this week.
